The Joint Corp. reported a notable financial performance for the third quarter of 2025, with total revenues reaching $13.4 million, a 5.7% increase from $12.7 million in the same period last year. The growth was primarily driven by a rise in royalty fees, which increased by 3.0% to $8.1 million, and franchise fees, which surged by 38.3% to $964,796. The company also saw a 4.3% increase in advertising fund revenue, totaling $2.3 million. For the nine months ending September 30, 2025, total revenues amounted to $39.7 million, up 6.1% from $37.4 million in the prior year.
In terms of profitability, The Joint Corp. reported a net income of $855,009 for the third quarter, a significant turnaround from a net loss of $3.2 million in the same quarter of 2024. This improvement was attributed to increased revenues and a reduction in costs, particularly in general and administrative expenses, which fell by 2.4% to $7.3 million. The company also experienced a decrease in total cost of revenues by 5.5% to $2.7 million, reflecting operational efficiencies.
Strategically, The Joint Corp. is actively pursuing a refranchising strategy, having sold or refranchised a total of 37 clinics in 2025, with plans to continue this trend. The company has focused on marketing its clinics in clusters to attract larger multi-unit operators and private equity firms. As of September 30, 2025, the company operated 962 clinics, with 884 being franchised. The company also announced an Asset Purchase Agreement to sell 45 clinics in Southern California for $4.5 million, furthering its refranchising efforts.
Operationally, The Joint Corp. reported a decrease in comparable same-store sales of 2.0% for clinics open for at least 13 months, and a 4.9% decline for mature clinics open for 48 months or more. The company’s total clinic count reflects a slight increase in franchised clinics, which rose from 838 to 884 year-over-year. The company continues to leverage its regional developer program, which accounted for 25% of the eight franchise licenses sold in the third quarter.
Looking ahead, The Joint Corp. anticipates a volatile macroeconomic environment in 2025, influenced by factors such as labor shortages, inflation, and rising interest rates. The company believes it has sufficient cash reserves and access to credit to meet its operational needs for the next 12 months. However, it acknowledges that ongoing economic uncertainties could impact its financial performance and operational strategies.
About JOINT Corp
The Joint Corp. operates a franchise-based network of chiropractic clinics offering affordable, cash-based, non-insurance services focused on routine wellness and pain management. With a large national footprint, the company emphasizes convenience, consumer-friendly environments, and a simplified business model that eliminates insurance processing. It aims to expand through franchise sales, support of regional developers, and strategic divestitures, positioning itself as a leading, scalable provider in the growing chiropractic industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.